Overexpression of astrocyte-elevated gene-1 is associated with cervical carcinoma progression and angiogenesis

Oncology Reports

Volumn 30, Issue 3, 2013, Pages 1414-1422

  Long, Min ^a   Dong, Ke ^a   Gao, Ping ^a   Wang, Xi ^a   Liu, Li ^a   Yang, Shuhui ^a   Lin, Fang ^a   Wei, Junxia ^a   Zhang, Huizhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AEG 1; Angiogenesis; Cervical carcinoma; Tumor marker

Indexed keywords

ANGIOPOIETIN RECEPTOR; ASTROCYTE ELEVATED GENE 1 PROTEIN; ENDOSIALIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ONCOPROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CD248 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HIF 1ALPHA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEM1 GENE; TIE2 GENE; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; UPREGULATION; UTERINE CERVIX CARCINOMA; VEGF GENE;

ANGIOGENESIS MODULATING AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84880602868     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2598     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Green JA, Kirwan JM, Tierney JF, et al: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358: 781-786, 2001.
3. Martin-Loeches M, Ortí RM, Cazorla E, Asins E and Lixiona J: Multivariate analysis of the morphometric characteristics of tumours as prognostic factors in the survival of patients with uterine cervix cancer treated with radical surgery. Eur J Obstet Gynecol Reprod Biol 105: 170-176, 2002.
4. Gasinska A, Urbanski K, Adamczyk A, Pudelek J, Lind BK and Brahme A: Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol 41: 437-443, 2002.
5. Goudy G, Stoeckle E, Thomas L, et al: Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix. Bull Cancer 96: 685-694, 2009 (In French)
6. Grigiene R, Valuckas KP, Aleknavicius E, Kurtinaitis J and Letautiene SR: The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone. BMC Cancer 7: 234, 2007.
7. Su ZZ, Kang DC, Chen Y, et al: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592-3602, 2002.
8. Brown DM and Ruoslahti E: Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374, 2004.
9. Sarkar D, Emdad L, Lee SG, Yoo BK, Su ZZ and Fisher PB: Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res 69: 8529-8535, 2009.
10. Liao WT, Guo L, Zhong Y, Wu YH, Li J and Song B: Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. J Transl Med 9: 205, 2011.
11. Liu L, Wu J, Ying Z, et al: Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 70: 3750-3759, 2010.
12. Yoo BK, Emdad L, Su ZZ, et al: Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119: 465-477, 2009.
13. Yu C, Chen K, Zheng H, et al: Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30: 894-901, 2009.
14. Li J, Zhang N, Song LB, et al: Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 3319-3326, 2008.
15. Kikuno N, Shiina H, Urakami S, et al: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26: 7647-7655, 2007.
16. Xu J-B, Wu H, He Y-L, Zhang C-H, Zhang, L-J, Cai S-R and Zhan W-H: Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol 28: 455-462, 2011.
17. Chen W, Ke Z, Shi H, Yang S and Wang L: Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 57: 522-529, 2010.
18. Song LB, Li W, Zhang HZ, et al: Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 219: 317-326, 2009.
19. Ash SC, Yang DQ and Britt DE: LYRIC/AEG-1 overexpression modulates BCCIPa protein levels in prostate tumor cells. Biochem Biophys Res Commun 371: 333-338, 2008.
20. Thirkettle HJ, Mills IG, Whitaker HC and Neal DE: Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 28: 3663-3670, 2009.
21. Li J, Yang L, Song L, et al: Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 28: 3188-3196, 2009.
22. Santarpia M, Magri I, Sanchez-Ronco M, et al: mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients. J Transl Med 9: 163, 2011.
23. Li C, Li R, Song H, et al: Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. J Surg Oncol 103: 184-192, 2011.
24. Hu GH, Chong RA, Yang QF, et al: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20, 2009.
25. Liu H, Song X, Liu C, Li X, Wei L and Sun R: Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 28: 19, 2009.
26. Yoo BK, Gredler R, Vozhilla N, et al: Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci USA 106: 12938-12943, 2009.
27. Lee SG, Su ZZ, Emdad L, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA 103: 17390-17395, 2006.
28. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27: 1114-1121, 2008.
29. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ and Fisher PB: Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 68: 1478-1484, 2008.
30. Emdad L, Sarkar D, Su ZZ, et al: Activation of the nuclear factor-kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 66: 1509-1516, 2006.
31. Xi W, Rui W, Fang L, Ke D, Ping G and Zhang H-Z: Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients. J Cancer Res Clin Oncol 135: 837-846, 2009.
32. Li B, Zhang LJ, Zhang ZL, et al: Synergistic tumor growth inhibition effect of prostate-specific antigen-activated fusion peptide BSD352 for prostate cancer therapy. Anticancer Drugs 22: 213-222, 2011.
33. Long M, Yin G, Liu L, et al: Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells. Cancer Gene Ther 19: 271-281, 2012.
34. Moore MA, Attasara P, Khuhaprema T, et al: Cancer epidemiology in mainland South-East Asia - past, present and future. Asian Pac J Cancer Prev 11 (Suppl 2): 67-80, 2010.
35. Folkman J: Tumor angiogenesis. Adv Cancer Res 43: 175-203, 1985.